Brief: Irlab's Drug Candidate Mesdopetam's Mechanism Of Action Receives Confirmation By Independent Scientists

IRLAB Therapeutics AB

25/03/2021 08:02

March 25 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB'S DRUG CANDIDATE MESDOPETAM'S MECHANISM OF ACTION
RECEIVES
CONFIRMATION BY INDEPENDENT SCIENTISTS
    * INDEPENDENT SCIENTISTS HAVE CONFIRMED THAT DOPAMINE D3
RECEPTOR
(D3R) IS A HIGHLY PROMISING DRUG TARGET WITH THERAPEUTIC
POTENTIAL IN LEVODOPA-INDUCED DYSKINESIA

Source text for Eikon:  ID:nWkr9NwZCy 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))